Search

Endocrine-disrupting chemicals (EDCs) substantially cost society as a result of increases in disease and disability but—unlike other toxicant classes such as carcinogens—have yet to be codified into regulations as a hazard category.This Series paper examines economic, regulatory, and policy approaches to limit human EDC exposures and describes potential improvements. In the EU, general principles for EDCs call for minimisation of human exposure, identification as substances of very high concern, and ban on use in pesticides. In the USA, screening and

Over the past decade a great amount of interest has arisen regarding the occurrence and fate of trace organic contaminants in the aquatic environment. Of particular concern are human hormones and pharmaceuticals, many of which are ubiquitous contaminants in conventional municipal wastewater treatment plant effluents when measured with ng/L detection limits. As analytical procedures and bioassay techniques become more readily available and increasingly sensitive, new contaminants will be discovered. The presence or absence of any chemical in a wastewater effluent

Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) are a group of chemical compounds with diverse physical and chemical properties. Recent studies have indicated undesired effects of EDCs and PPCPs at their reported trace concentrations. This paper reviews the current knowledge on the sources, properties, occurrence and health impacts of EDCs and PPCPs, and their removal from drinking water using ozonation and ozone/hydrogen peroxide-based advanced oxidation. The paper also examines the potential threats posed by these chemicals